Comparing incident diabetes as defined by fasting plasma glucose or by HbA 1c. The AusDiab, Inter99 and DESIR studies

S. Soulimane, D. Simon, J. E. Shaw, P. Z. Zimmet, S. Vol, D. Vistisen, D. J. Magliano, K. Borch-Johnsen, B. Balkau

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Aim: We examined the ability of fasting plasma glucose and HbA 1c to predict 5-year incident diabetes for an Australian cohort and a Danish cohort and 6-year incident diabetes for a French cohort, as defined by the corresponding criteria. Methods We studied 6025 men and women from AusDiab (Australian), 4703 from Inter99 (Danish) and 3784 from DESIR (French), not treated for diabetes and with fasting plasma glucose <7.0mmol/l and HbA 1c<48mmol/mol (6.5%) at inclusion. Diabetes was defined as fasting plasma glucose ≥7.0mmol/l and/or treatment for diabetes or as HbA 1c≥48mmol/mol (6.5%) and/or treatment for diabetes. Results For AusDiab, incident fasting plasma glucose-defined diabetes was more frequent than HbA 1c-defined diabetes (P McNemar<0.0001), the reverse applied to Inter99 (P McNemar<0.007) and for DESIR there was no difference (P McNema=0.17). Less than one third of the incident cases were detected by both criteria. Logistic regression models showed that baseline fasting plasma glucose and baseline HbA 1c predicted incident diabetes defined by the corresponding criteria. The standardized odds ratios (95% confidence interval) for HbA 1c were a little higher than for fasting plasma glucose, but not significantly so. They were respectively, 5.0 (4.1-6.1) and 4.1 (3.5-4.9) for AusDiab, 5.0 (3.6-6.8) and 4.8 (3.6-6.3) for Inter99, 4.8 (3.6-6.5) and 4.6 (3.6-5.9) for DESIR. Conclusions Fasting plasma glucose and HbA 1c are good predictors of incident diabetes defined by the corresponding criteria. Despite Diabetes Control and Complications Trial-alignment of the three HbA 1c assays, there was a large difference in the HbA 1c distributions between these studies, conducted some 10years ago. Thus, it is difficult to compare absolute values of diabetes prevalence and incidence based on HbA 1c measurements from that time.

LanguageEnglish
Pages1311-1318
Number of pages8
JournalDiabetic Medicine
Volume28
Issue number11
DOIs
Publication statusPublished - 1 Nov 2011
Externally publishedYes

Keywords

  • Fasting plasma glucose
  • HbA
  • Incident diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Soulimane, S., Simon, D., Shaw, J. E., Zimmet, P. Z., Vol, S., Vistisen, D., ... Balkau, B. (2011). Comparing incident diabetes as defined by fasting plasma glucose or by HbA 1c. The AusDiab, Inter99 and DESIR studies. Diabetic Medicine, 28(11), 1311-1318. https://doi.org/10.1111/j.1464-5491.2011.03403.x
Soulimane, S. ; Simon, D. ; Shaw, J. E. ; Zimmet, P. Z. ; Vol, S. ; Vistisen, D. ; Magliano, D. J. ; Borch-Johnsen, K. ; Balkau, B. / Comparing incident diabetes as defined by fasting plasma glucose or by HbA 1c. The AusDiab, Inter99 and DESIR studies. In: Diabetic Medicine. 2011 ; Vol. 28, No. 11. pp. 1311-1318.
@article{954b018655454ef0a3f52cd094b00e43,
title = "Comparing incident diabetes as defined by fasting plasma glucose or by HbA 1c. The AusDiab, Inter99 and DESIR studies",
abstract = "Aim: We examined the ability of fasting plasma glucose and HbA 1c to predict 5-year incident diabetes for an Australian cohort and a Danish cohort and 6-year incident diabetes for a French cohort, as defined by the corresponding criteria. Methods We studied 6025 men and women from AusDiab (Australian), 4703 from Inter99 (Danish) and 3784 from DESIR (French), not treated for diabetes and with fasting plasma glucose <7.0mmol/l and HbA 1c<48mmol/mol (6.5{\%}) at inclusion. Diabetes was defined as fasting plasma glucose ≥7.0mmol/l and/or treatment for diabetes or as HbA 1c≥48mmol/mol (6.5{\%}) and/or treatment for diabetes. Results For AusDiab, incident fasting plasma glucose-defined diabetes was more frequent than HbA 1c-defined diabetes (P McNemar<0.0001), the reverse applied to Inter99 (P McNemar<0.007) and for DESIR there was no difference (P McNema=0.17). Less than one third of the incident cases were detected by both criteria. Logistic regression models showed that baseline fasting plasma glucose and baseline HbA 1c predicted incident diabetes defined by the corresponding criteria. The standardized odds ratios (95{\%} confidence interval) for HbA 1c were a little higher than for fasting plasma glucose, but not significantly so. They were respectively, 5.0 (4.1-6.1) and 4.1 (3.5-4.9) for AusDiab, 5.0 (3.6-6.8) and 4.8 (3.6-6.3) for Inter99, 4.8 (3.6-6.5) and 4.6 (3.6-5.9) for DESIR. Conclusions Fasting plasma glucose and HbA 1c are good predictors of incident diabetes defined by the corresponding criteria. Despite Diabetes Control and Complications Trial-alignment of the three HbA 1c assays, there was a large difference in the HbA 1c distributions between these studies, conducted some 10years ago. Thus, it is difficult to compare absolute values of diabetes prevalence and incidence based on HbA 1c measurements from that time.",
keywords = "Fasting plasma glucose, HbA, Incident diabetes",
author = "S. Soulimane and D. Simon and Shaw, {J. E.} and Zimmet, {P. Z.} and S. Vol and D. Vistisen and Magliano, {D. J.} and K. Borch-Johnsen and B. Balkau",
year = "2011",
month = "11",
day = "1",
doi = "10.1111/j.1464-5491.2011.03403.x",
language = "English",
volume = "28",
pages = "1311--1318",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",
number = "11",

}

Soulimane, S, Simon, D, Shaw, JE, Zimmet, PZ, Vol, S, Vistisen, D, Magliano, DJ, Borch-Johnsen, K & Balkau, B 2011, 'Comparing incident diabetes as defined by fasting plasma glucose or by HbA 1c. The AusDiab, Inter99 and DESIR studies', Diabetic Medicine, vol. 28, no. 11, pp. 1311-1318. https://doi.org/10.1111/j.1464-5491.2011.03403.x

Comparing incident diabetes as defined by fasting plasma glucose or by HbA 1c. The AusDiab, Inter99 and DESIR studies. / Soulimane, S.; Simon, D.; Shaw, J. E.; Zimmet, P. Z.; Vol, S.; Vistisen, D.; Magliano, D. J.; Borch-Johnsen, K.; Balkau, B.

In: Diabetic Medicine, Vol. 28, No. 11, 01.11.2011, p. 1311-1318.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Comparing incident diabetes as defined by fasting plasma glucose or by HbA 1c. The AusDiab, Inter99 and DESIR studies

AU - Soulimane, S.

AU - Simon, D.

AU - Shaw, J. E.

AU - Zimmet, P. Z.

AU - Vol, S.

AU - Vistisen, D.

AU - Magliano, D. J.

AU - Borch-Johnsen, K.

AU - Balkau, B.

PY - 2011/11/1

Y1 - 2011/11/1

N2 - Aim: We examined the ability of fasting plasma glucose and HbA 1c to predict 5-year incident diabetes for an Australian cohort and a Danish cohort and 6-year incident diabetes for a French cohort, as defined by the corresponding criteria. Methods We studied 6025 men and women from AusDiab (Australian), 4703 from Inter99 (Danish) and 3784 from DESIR (French), not treated for diabetes and with fasting plasma glucose <7.0mmol/l and HbA 1c<48mmol/mol (6.5%) at inclusion. Diabetes was defined as fasting plasma glucose ≥7.0mmol/l and/or treatment for diabetes or as HbA 1c≥48mmol/mol (6.5%) and/or treatment for diabetes. Results For AusDiab, incident fasting plasma glucose-defined diabetes was more frequent than HbA 1c-defined diabetes (P McNemar<0.0001), the reverse applied to Inter99 (P McNemar<0.007) and for DESIR there was no difference (P McNema=0.17). Less than one third of the incident cases were detected by both criteria. Logistic regression models showed that baseline fasting plasma glucose and baseline HbA 1c predicted incident diabetes defined by the corresponding criteria. The standardized odds ratios (95% confidence interval) for HbA 1c were a little higher than for fasting plasma glucose, but not significantly so. They were respectively, 5.0 (4.1-6.1) and 4.1 (3.5-4.9) for AusDiab, 5.0 (3.6-6.8) and 4.8 (3.6-6.3) for Inter99, 4.8 (3.6-6.5) and 4.6 (3.6-5.9) for DESIR. Conclusions Fasting plasma glucose and HbA 1c are good predictors of incident diabetes defined by the corresponding criteria. Despite Diabetes Control and Complications Trial-alignment of the three HbA 1c assays, there was a large difference in the HbA 1c distributions between these studies, conducted some 10years ago. Thus, it is difficult to compare absolute values of diabetes prevalence and incidence based on HbA 1c measurements from that time.

AB - Aim: We examined the ability of fasting plasma glucose and HbA 1c to predict 5-year incident diabetes for an Australian cohort and a Danish cohort and 6-year incident diabetes for a French cohort, as defined by the corresponding criteria. Methods We studied 6025 men and women from AusDiab (Australian), 4703 from Inter99 (Danish) and 3784 from DESIR (French), not treated for diabetes and with fasting plasma glucose <7.0mmol/l and HbA 1c<48mmol/mol (6.5%) at inclusion. Diabetes was defined as fasting plasma glucose ≥7.0mmol/l and/or treatment for diabetes or as HbA 1c≥48mmol/mol (6.5%) and/or treatment for diabetes. Results For AusDiab, incident fasting plasma glucose-defined diabetes was more frequent than HbA 1c-defined diabetes (P McNemar<0.0001), the reverse applied to Inter99 (P McNemar<0.007) and for DESIR there was no difference (P McNema=0.17). Less than one third of the incident cases were detected by both criteria. Logistic regression models showed that baseline fasting plasma glucose and baseline HbA 1c predicted incident diabetes defined by the corresponding criteria. The standardized odds ratios (95% confidence interval) for HbA 1c were a little higher than for fasting plasma glucose, but not significantly so. They were respectively, 5.0 (4.1-6.1) and 4.1 (3.5-4.9) for AusDiab, 5.0 (3.6-6.8) and 4.8 (3.6-6.3) for Inter99, 4.8 (3.6-6.5) and 4.6 (3.6-5.9) for DESIR. Conclusions Fasting plasma glucose and HbA 1c are good predictors of incident diabetes defined by the corresponding criteria. Despite Diabetes Control and Complications Trial-alignment of the three HbA 1c assays, there was a large difference in the HbA 1c distributions between these studies, conducted some 10years ago. Thus, it is difficult to compare absolute values of diabetes prevalence and incidence based on HbA 1c measurements from that time.

KW - Fasting plasma glucose

KW - HbA

KW - Incident diabetes

UR - http://www.scopus.com/inward/record.url?scp=80054698863&partnerID=8YFLogxK

U2 - 10.1111/j.1464-5491.2011.03403.x

DO - 10.1111/j.1464-5491.2011.03403.x

M3 - Article

VL - 28

SP - 1311

EP - 1318

JO - Diabetic Medicine

T2 - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 11

ER -